Introduction: Despite the abundance of research indicating the participation of immune cells
in prostate cancer development, establishing a definitive cause-and-effect relationship has …

Background There is still limited research on the association between immune cells and the
risk of prostate cancer. Further investigations are warranted to comprehend the intricate …

Background Previous research has focused on the association between immune cells and
the development of benign prostatic hyperplasia (BPH). Nevertheless, the causal …

Background Over the past few decades, immunological checkpoint therapy has been an
increasingly prominent strategy in the treatment of tumors, including prostate cancer (PC) …

Background Prostate cancer (PCa) is an immune-responsive disease. The current study
sought to explore a robust immune-related prognostic gene signature for PCa. Methods …

Background This study was to explore the infiltration pattern of immune cells in the prostate
cancer (PCa) microenvironment and evaluate the possibility of specific infiltrating immune …

Background Immunotherapy has been less successful in treating prostate cancer than other
solid tumors. We sought to better understand the immune landscape in prostate cancer and …

Prostate cancer is the most common malignancy in the reproductive system of older males.
Androgen deprivation therapy (ADT) is an important treatment for prostate cancer patients …

Purpose: The role of immune-oncologic mechanisms of racial disparities in prostate cancer
remains understudied. Limited research exists to evaluate the molecular underpinnings of …

Background Biliary tract cancer stands as a prevalent illness, posing significant risks to
human health, where immune cells are pivotal in both its development and recovery …